Principal Financial Group Inc Royalty Pharma PLC Transaction History

Principal Financial Group Inc

$184 Billion
Q3 2025

A detailed history of Principal Financial Group Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Principal Financial Group Inc holds 14,188 shares of RPRX stock, worth $555,602. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,188

Previous 16,304 12.98%

Holding current value

$555,602

Previous $587,000 14.82%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	SELL	$34.9 - $37.91 $73,848 - $80,217	-2,116 Reduced 12.98%	14,188 $500,000
Q2 2025 Aug 08, 2025	SELL	$30.85 - $36.14 $82,246 - $96,349	-2,666 Reduced 14.05%	16,304 $587,000
Q1 2025 Apr 28, 2025	SELL	$25.75 - $33.86 $29,509 - $38,803	-1,146 Reduced 5.7%	18,970 $590,000
Q4 2024 Jan 31, 2025	BUY	$24.28 - $28.39 $488,416 - $571,093	20,116 New	20,116 $513,000
Q3 2024 Oct 31, 2024	SELL	$25.63 - $29.27 $94,933 - $108,416	-3,704 Reduced 12.72%	25,409 $718,000

Q2 2024 Jul 29, 2024	SELL	$26.26 - $29.9 $62,288 - $70,922	-2,372 Reduced 7.53%	29,113 $767,000
Q1 2024 Apr 29, 2024	BUY	$27.46 - $31.33 $222,041 - $253,334	8,086 Added 34.56%	31,485 $956,000
Q4 2023 Feb 07, 2024	SELL	$26.21 - $29.22 $151,493 - $168,891	-5,780 Reduced 19.81%	23,399 $657,000
Q3 2023 Nov 02, 2023	BUY	$26.26 - $31.38 $39,757 - $47,509	1,514 Added 5.47%	29,179 $791,000
Q2 2023 Aug 07, 2023	SELL	$29.6 - $36.56 $280,756 - $346,771	-9,485 Reduced 25.53%	27,665 $850,000
Q1 2023 May 09, 2023	BUY	$32.77 - $39.4 $50,072 - $60,203	1,528 Added 4.29%	37,150 $1.34 Million
Q4 2022 Feb 09, 2023	SELL	$39.17 - $44.04 $196,907 - $221,389	-5,027 Reduced 12.37%	35,622 $1.41 Million
Q3 2022 Nov 09, 2022	SELL	$39.88 - $44.65 $230,626 - $258,210	-5,783 Reduced 12.45%	40,649 $1.63 Million
Q2 2022 Aug 10, 2022	BUY	$37.53 - $44.22 $231,747 - $273,058	6,175 Added 15.34%	46,432 $1.95 Million
Q1 2022 May 09, 2022	BUY	$37.46 - $42.44 $81,213 - $92,009	2,168 Added 5.69%	40,257 $1.57 Million
Q4 2021 Feb 09, 2022	BUY	$35.17 - $42.48 $276,893 - $334,445	7,873 Added 26.06%	38,089 $1.52 Million
Q3 2021 Nov 09, 2021	SELL	$36.14 - $42.24 $54,462 - $63,655	-1,507 Reduced 4.75%	30,216 $1.09 Million
Q2 2021 Aug 10, 2021	BUY	$39.85 - $46.63 $154,458 - $180,737	3,876 Added 13.92%	31,723 $1.3 Million
Q1 2021 May 10, 2021	BUY	$42.34 - $52.82 $603,599 - $753,001	14,256 Added 104.89%	27,847 $1.22 Million
Q4 2020 Feb 08, 2021	SELL	$36.12 - $50.05 $136,678 - $189,389	-3,784 Reduced 21.78%	13,591 $680,000
Q3 2020 Nov 06, 2020	BUY	$38.56 - $48.36 $245,820 - $308,295	6,375 Added 57.95%	17,375 $730,000
Q2 2020 Sep 04, 2020	BUY	$44.5 - $52.11 $489,500 - $573,210	11,000 New	11,000 $534,000

Others Institutions Holding RPRX

# of Institutions

534

Shares Held

304M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Royalty Pharma PLC Transaction History